EUVIMEDEUVIMED entdecken
Crossref

MicroRNAs in preeclampsia: novel promising genetic diagnostic and prognostic biomarkers

Asparuh Nikolov, Nikola Popovski, Nikoleta Stoyanova, Valeria Racheva

Romanian Medical Journal · 31.03.2026 · 73 (1) · 146

DOI: 10.37897/rmj.2026.1.19 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Romanian Medical Journal, online erschienen am 17.03.2026. Verfasst von Asparuh Nikolov und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Preeclampsia (PE) complicates 2–8% of pregnancies worldwide. PE is a hypertensive disorder of pregnancy, defined by the occurrence of new-onset hypertension (>140/90 mmHg) and either proteinuria (0.3 g in a 24 h urine sample) or end-organ dysfunction developing after 20 weeks of gestation. Preeclampsia remains a condition that is not yet fully understood. It is a major cause of maternal and perinatal morbidity and mortality. Its early diagnosis is of cardinal importance for a successful delivery and the prevention of future complications affecting the mother and fetus. Nowadays, there is an increasing interest in PE markers. A growing number of studies on biomarkers in PE reveal microRNAs (miRNAs) as significant regulators, providing insight into the molecular mechanisms underlying placental dysfunction and impaired maternal adaptation.

Objective

The present paper summarizes and critically evaluates recent understanding of miRNA research in patients with PE. It presents a current overview of the general characteristics of miRNAs. The future prospects of potential clinical application of miRNAs as diagnostic and prognostic markers are also emphasized.

Methods

A narrative review of the literature was performed, focusing on pathogenesis, clinical and experimental studies that examined miRNAs in PE, with special focus on current investigations.

Results

Recent studies in the field of PE demonstrate the valuable role of miRNAs as promising non-invasive indicators for early diagnosis, prognosis, and risk stratification of PE.

Conclusion

The use of appropriate biomarkers would allow accurate risk stratification for the purpose of early detection of PE and the implementation of timely therapy. MicroRNAs have promising potential for clinical application as PE diagnostic and prognostic indicators.

Zitieren

APA

Nikolov, A., Popovski, N., Stoyanova, N., & Racheva, V. (2026). MicroRNAs in preeclampsia: novel promising genetic diagnostic and prognostic biomarkers. Romanian Medical Journal, 73(1), 146. https://doi.org/10.37897/rmj.2026.1.19

Vancouver

Nikolov A, Popovski N, Stoyanova N, Racheva V. MicroRNAs in preeclampsia: novel promising genetic diagnostic and prognostic biomarkers. Romanian Medical Journal. 2026;73(1):146. doi:10.37897/rmj.2026.1.19

BibTeX
@article{Nikolov2026,
  author = {Nikolov, Asparuh and Popovski, Nikola and Stoyanova, Nikoleta and Racheva, Valeria},
  title = {MicroRNAs in preeclampsia: novel promising genetic diagnostic and prognostic biomarkers},
  journal = {Romanian Medical Journal},
  year = {2026},
  volume = {73},
  number = {1},
  pages = {146},
  doi = {10.37897/rmj.2026.1.19}
}
Kostenlos starten →